Stock listing
NASDAQ:XLO Xilio Therapeutics, Inc. Stock
Home listing (NASDAQ) of Xilio Therapeutics, Inc.
Follow Xilio Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:XLO
$8.03 USD +0.26 (+3.3%)
Close on Oct 30, 2026
- Day range
- $7.05 – $8.09 USDOct 30, 2026
- Volume
- 7,720 sharesOct 30, 2026
- Market cap
- $52.84M USDAt the close on Oct 30, 2026 · price × 6.58M shares outstanding
- 52-week range
- $6.47 – $12.32 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $108,309 USDMedian day 9,650 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:XLO · Home | $8.03 USD | +0.26 (+3.3%) | 7,720 | $7.05 | $8.089 | $7.05 | $7.77 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:XLO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.03 | +0.26 | +3.3% | $7.05 | $8.089 | $7.05 | 7,720 | |
| $7.77 | -0.24 | -3.0% | $7.93 | $7.93 | $7.77 | 2,588 | |
| $8.01 | 0.00 | 0.0% | $7.81 | $8.19 | $7.57 | 16,674 | |
| $8.01 | +0.70 | +9.6% | $7.855 | $8.01 | $7.17 | 27,920 | |
| $7.31 | -0.26 | -3.4% | $7.54 | $8.637 | $7.05 | 33,066 | |
| $7.57 | -0.46 | -5.7% | $8.06 | $8.245 | $7.51 | 16,300 | |
| $8.03 | -0.40 | -4.7% | $8.45 | $8.48 | $8.00 | 15,400 | |
| $8.43 | -0.11 | -1.3% | $8.545 | $9.05 | $8.249 | 36,300 | |
| $8.54 | +0.21 | +2.5% | $8.25 | $8.84 | $8.25 | 13,500 | |
| $8.33 | -0.22 | -2.6% | $8.69 | $8.735 | $8.33 | 11,500 | |
| $8.55 | -0.47 | -5.2% | $8.91 | $9.00 | $8.55 | 29,600 | |
| $9.02 | +0.12 | +1.3% | $8.88 | $9.38 | $8.88 | 10,400 | |
| $8.90 | -0.32 | -3.5% | $9.08 | $9.08 | $8.772 | 12,400 | |
| $9.22 | +0.145 | +1.6% | $9.05 | $9.22 | $8.855 | 18,100 | |
| $9.075 | +0.025 | +0.3% | $9.11 | $9.42 | $8.982 | 8,400 | |
| $9.05 | +0.04 | +0.4% | $8.94 | $9.16 | $8.82 | 5,500 | |
| $9.01 | 0.00 | 0.0% | $9.01 | $9.14 | $8.775 | 20,800 | |
| $9.01 | +0.01 | +0.1% | $9.00 | $9.01 | $9.00 | 900 | |
| $9.00 | -0.11 | -1.2% | $9.10 | $9.32 | $8.81 | 6,200 | |
| $9.11 | +0.10 | +1.1% | $9.07 | $9.49 | $9.07 | 7,200 | |
| $9.01 | +0.10 | +1.1% | $8.89 | $9.075 | $8.89 | 7,400 | |
| $8.91 | -0.14 | -1.5% | $8.97 | $9.12 | $8.79 | 12,900 | |
| $9.05 | +0.112 | +1.3% | $9.19 | $9.25 | $9.05 | 5,400 | |
| $8.938 | -0.112 | -1.2% | $9.568 | $9.568 | $8.938 | 3,100 | |
| $9.05 | +0.01 | +0.1% | $9.21 | $9.22 | $8.96 | 11,100 | |
| $9.04 | +0.04 | +0.4% | $9.00 | $9.21 | $8.93 | 3,400 | |
| $9.00 | +0.06 | +0.7% | $8.93 | $9.09 | $8.93 | 16,000 | |
| $8.94 | -0.10 | -1.1% | $9.03 | $9.04 | $8.94 | 1,300 | |
| $9.04 | +0.02 | +0.2% | $9.04 | $9.16 | $8.95 | 6,900 | |
| $9.02 | -0.11 | -1.2% | $8.96 | $9.175 | $8.96 | 7,100 | |
| $9.13 | +0.09 | +1.0% | $8.995 | $9.67 | $8.94 | 22,900 | |
| $9.04 | +0.06 | +0.7% | $9.00 | $9.049 | $8.93 | 14,500 | |
| $8.98 | -0.05 | -0.6% | $9.02 | $9.02 | $8.93 | 11,500 | |
| $9.03 | +0.10 | +1.1% | $8.93 | $9.03 | $8.93 | 17,300 | |
| $8.93 | 0.00 | 0.0% | $9.06 | $9.21 | $8.93 | 10,300 | |
| $8.93 | 0.00 | 0.0% | $8.93 | $9.49 | $8.93 | 5,100 | |
| $8.93 | -0.04 | -0.4% | $8.95 | $9.00 | $8.93 | 11,800 | |
| $8.97 | +0.06 | +0.7% | $8.91 | $9.00 | $8.80 | 9,000 | |
| $8.91 | -0.09 | -1.0% | $9.03 | $9.11 | $8.81 | 10,000 | |
| $9.00 | -0.02 | -0.2% | $9.231 | $9.231 | $8.81 | 7,600 | |
| $9.02 | +0.18 | +2.0% | $8.94 | $9.10 | $8.721 | 6,600 | |
| $8.84 | -0.04 | -0.5% | $9.142 | $9.142 | $8.84 | 4,700 | |
| $8.88 | -0.07 | -0.8% | $8.57 | $9.248 | $8.57 | 31,100 | |
| $8.95 | -0.05 | -0.6% | $9.00 | $9.27 | $8.90 | 14,600 | |
| $9.00 | -0.01 | -0.1% | $8.995 | $9.28 | $8.995 | 3,600 | |
| $9.01 | -0.04 | -0.4% | $8.785 | $9.115 | $8.785 | 9,000 | |
| $9.05 | -0.03 | -0.3% | $9.09 | $9.145 | $8.922 | 7,700 | |
| $9.08 | -0.11 | -1.2% | $9.16 | $9.30 | $9.08 | 5,895 | |
| $9.19 | -0.04 | -0.4% | $9.32 | $9.32 | $9.17 | 2,293 | |
| $9.23 | 0.00 | 0.0% | $9.21 | $9.23 | $9.07 | 5,200 | |
| $9.23 | -0.18 | -1.9% | $9.27 | $9.27 | $9.11 | 6,400 | |
| $9.41 | -0.09 | -0.9% | $9.44 | $9.48 | $9.119 | 6,900 | |
| $9.50 | +0.01 | +0.1% | $9.50 | $9.65 | $9.21 | 13,000 | |
| $9.49 | +0.32 | +3.5% | $9.07 | $9.90 | $9.07 | 46,500 | |
| $9.17 | +0.16 | +1.8% | $9.135 | $9.27 | $8.685 | 8,100 | |
| $9.01 | -0.04 | -0.4% | $9.05 | $9.28 | $8.90 | 13,400 | |
| $9.05 | -0.13 | -1.4% | $9.18 | $9.18 | $8.781 | 9,300 | |
| $9.18 | -0.02 | -0.2% | $9.01 | $9.19 | $9.01 | 6,200 | |
| $9.20 | +0.03 | +0.3% | $8.80 | $9.25 | $8.80 | 6,600 | |
| $9.17 | -0.10 | -1.1% | $9.40 | $9.40 | $8.88 | 11,500 | |
| $9.27 | +0.16 | +1.8% | $9.11 | $9.62 | $9.02 | 34,300 | |
| $9.11 | +0.02 | +0.2% | $9.21 | $9.21 | $8.975 | 6,100 | |
| $9.09 | +0.04 | +0.4% | $9.165 | $9.24 | $8.975 | 20,500 | |
| $9.05 | -0.06 | -0.7% | $9.16 | $9.375 | $9.00 | 18,800 | |
| $9.11 | +0.03 | +0.3% | $9.00 | $9.16 | $8.89 | 11,400 | |
| $9.08 | -0.02 | -0.2% | $8.96 | $9.305 | $8.82 | 5,000 |
- Ticker
- NASDAQ:XLO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
Latest deck · Mar 9, 2026
Investor Presentation (March 2026)
Investor deck · 36 slides
Latest news
Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
Oct 26, 2026
Closed $7.31 (-3.4%) on Oct 26, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $9.11 (+1.1%) on Oct 5, 2026
Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer
Sep 28, 2026
Closed $9.05 (+0.1%) on Sep 28, 2026
Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
Aug 12, 2026
Closed $9.05 (-1.4%) on Aug 12, 2026
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
Jun 29, 2026
Closed $9.27 (+2.4%) on Jun 29, 2026
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
May 12, 2026
Closed $7.73 (0.0%) on May 12, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 7, 2026
May 11, 2026
Closed $7.73 (-0.1%) on May 11, 2026
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
Apr 17, 2026
Closed $8.45 (-1.4%) on Apr 20, 2026
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
Apr 16, 2026
Closed $8.35 (-0.6%) on Apr 16, 2026
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Mar 23, 2026
Closed $7.86 (0.0%) on Mar 23, 2026
Decks
Investor Presentation (March 2026)
Investor deck · 36 slides · Mar 9, 2026
Investor Presentation (June 2025)
Investor deck · 44 slides · Jun 2, 2025
Investor Presentation (January 2025)
Investor deck · 43 slides · Jan 21, 2025
Investor Presentation (December 2024)
Investor deck · 42 slides · Dec 19, 2024
Xilio Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 69 in all · newest Oct 26, 2026 · oldest 2021
- Decks
- 11 decks · latest Mar 9, 2026
Where Xilio Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:XLO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:XLO | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Xilio Therapeutics, Inc.